"Truveta Studio is the first data and analytics solution to study patient care and outcomes for all conditions, drugs, and medical devices. Pfizer is using Truveta Studio to study COVID-19."
"We must work toward both human safety and environmental safety, and because our products typically prevent issues such as seepage and contamination of the soil and groundwater, mistakes can be very dangerous."
"Advanced data analysis is a huge growth area, and we are overloaded with opportunities for our team to address issues to optimize operations at the study and operational stages."
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."
MANAGING DIRECTOR AND CEO, METEORIC BIOPHARMACEUTICALS
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
"The Rio Tinto investment made was at a very favorable valuation which was less dilutive for our shareholders than a traditional financing, as well as being a considerable endorsement from one of the world’s largest mining companies."
"Dasa is the largest and highest-grade uranium deposit under development in Africa. We are excited to have started the underground development and look forward to transitioning from explorer to developer to a new uranium producer."
The Latam North and Caribbean Mining 2025 report adopts a regional formula to promote cross-border investment. Each country is given room to shine individually, while also being
woven into broader narratives.